Contract 75N94022P00382
Us Specialty Formulations Llc · Department Of Health And Human Services · May 18, 2022
Us Specialty Formulations Llc was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on May 18, 2022 for $58,000 of work in pharmaceutical preparation manufacturing. Performance is in Allentown, PA. It was awarded under a small business set-aside. It uses firm fixed-price contract pricing. If all options are exercised, the contract could reach $238,000.
Contract details
- PIID
- 75N94022P00382
- Award type
- Purchase Order
- Pricing
- Firm Fixed Price
- Set-aside
- Small Business Set Aside - Total
- Competition
- Competed Under Sap
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Laboratory Equipment And Supplies
- Place of performance
- Allentown, PA
- First action
- May 18, 2022
Description
NICHD SUPPLIES: STERILE INJECTABLES
Modification timeline
-
May 18, 2022Base award$58.1K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Four Points Technology, L.L.C. | Department Of Health And Human Services | March 31, 2026 | $246.6K |
| Astrazeneca Pharmaceuticals Lp | Department Of Health And Human Services | March 31, 2026 | $122.8K |
| Ase Direct, Inc. | Department Of Health And Human Services | March 30, 2026 | $49.0K |
| Mckesson Corporation | Department Of Health And Human Services | March 30, 2026 | $9.00M |
| Emergent Biosolutions Canada Inc | Department Of Health And Human Services | March 30, 2026 | $256.40M |
| Sanofi Vaccines Us Inc. | Department Of Health And Human Services | March 27, 2026 | $92.33M |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 53,729 | $99.76B |
| 2 | Pfizer Inc | 4,613 | $28.68B |
| 3 | Merck Sharp & Dohme Llc | 391 | $21.58B |
| 4 | Modernatx, Inc. | 3 | $8.20B |
| 5 | Sanofi Vaccines Us Inc. | 5,248 | $7.76B |
| 6 | Glaxosmithkline, Llc | 1,418 | $7.22B |
| 7 | Merck Sharp & Dohme Corp. | 349 | $5.33B |
| 8 | Pfizer Inc. | 3,842 | $4.83B |
| 9 | Eli Lilly And Company | 18 | $4.67B |
| 10 | Amerisourcebergen Drug Corp | 497 | $3.23B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75N94022P00382?
Contract 75N94022P00382 is a federal contract awarded to Us Specialty Formulations Llc by Department Of Health And Human Services on May 18, 2022 for $58,000 of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 0 times since the base award.
Who won contract 75N94022P00382?
Us Specialty Formulations Llc won contract 75N94022P00382 from Department Of Health And Human Services.
How much is contract 75N94022P00382 worth?
Contract 75N94022P00382 has obligated $58,000 to date, with a total potential value of $238,000 if all options are exercised.